Triphase Accelerator to Present Investigational New Drug Enabling Data...

Triphase Accelerator Corporation, a company dedicated to acquiring and developing novel therapeutics for the treatment of cancer, and Catalent, the leading global provider of advanced delivery...(PRWeb December 04, 2017)Read the full story at http://www.prweb.com/releases/2017/12/prweb14977095.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news